Growing tumor vessels: More than one way to skin a cat – Implications for angiogenesis targeted cancer therapies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Allegra, 2011, Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08, J. Clin. Oncol., 29, 11, 10.1200/JCO.2010.30.0855
Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964
Augustin, 2009, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system, Nat. Rev. Mol. Cell Biol., 10, 165, 10.1038/nrm2639
Baar, 2009, A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers, Clin. Cancer Res., 15, 3583, 10.1158/1078-0432.CCR-08-2917
Bagri, 2010, Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy, Clin. Cancer Res., 16, 3887, 10.1158/1078-0432.CCR-09-3100
Batchelor, 2007, AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients, Cancer Cell, 11, 83, 10.1016/j.ccr.2006.11.021
Belicchi, 2004, Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain, J. Neurosci. Res., 77, 475, 10.1002/jnr.20151
Belizon, 2006, Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods, Ann. Surg., 244, 792, 10.1097/01.sla.0000225272.52313.e2
Bellomo, 2000, Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia, Circ. Res., 86, E29, 10.1161/01.RES.86.2.e29
Bertolini, 2006, The multifaceted circulating endothelial cell in cancer: towards marker and target identification, Nat. Rev. Cancer, 6, 835, 10.1038/nrc1971
Black, 1993, Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy, N. Engl. J. Med., 328, 1237, 10.1056/NEJM199304293281706
Blinder, 2008, The role of environmental factors in the etiology of lymphoma, Cancer Invest., 26, 306, 10.1080/07357900701805686
Bruno, 2006, CD133+ renal progenitor cells contribute to tumor angiogenesis, Am. J. Pathol., 169, 2223, 10.2353/ajpath.2006.060498
Burri, 2004, Intussusceptive angiogenesis: its emergence, its characteristics, and its significance, Dev. Dyn., 231, 474, 10.1002/dvdy.20184
Cacheux, 2008, Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery, Ann. Oncol., 19, 1659, 10.1093/annonc/mdn540
Carmeliet, 1996, Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele, Nature, 380, 435, 10.1038/380435a0
Carmeliet, 2001, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions, Nat. Med., 7, 575, 10.1038/87904
Carmeliet, 2009, Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way, Nat. Rev. Clin. Oncol., 6, 315, 10.1038/nrclinonc.2009.64
Chang, 2000, Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood, Proc. Natl. Acad. Sci. USA, 97, 14608, 10.1073/pnas.97.26.14608
Chappell, 2009, Local guidance of emerging vessel sprouts requires soluble Flt-1, Dev. Cell, 17, 377, 10.1016/j.devcel.2009.07.011
Chen, 2007, Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study, J. Clin. Oncol., 25, 4714, 10.1200/JCO.2006.10.5825
Christofori, 2011, Metastatic colon cancer cells negotiate the intravasation Notch, Cancer Cell, 19, 6, 10.1016/j.ccr.2011.01.003
Chun, 2009, Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases, Jama, 302, 2338, 10.1001/jama.2009.1755
Clarijs, 2002, Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma, Invest. Ophthalmol. Vis. Sci., 43, 912
Crawford, 2009, VEGF inhibition: insights from preclinical and clinical studies, Cell Tissue Res., 335, 261, 10.1007/s00441-008-0675-8
Crawford, 2009, PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment, Cancer Cell, 15, 21, 10.1016/j.ccr.2008.12.004
Crivellato, 2004, Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo, Leukemia, 18, 331, 10.1038/sj.leu.2403246
Davidoff, 2001, Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 7, 2870
De Bock, 2009, Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells, J. Mol. Med., 87, 561, 10.1007/s00109-009-0482-z
De Palma, 2003, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nat. Med., 9, 789, 10.1038/nm871
De Palma, 2005, Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 8, 211, 10.1016/j.ccr.2005.08.002
Dejana, 2004, Endothelial cell-cell junctions: happy together, Nat. Rev. Mol. Cell Biol., 5, 261, 10.1038/nrm1357
di Tomaso, 2011, Glioblastoma recurrence after cediranib therapy in patients: lack of “rebound” revascularization as mode of escape, Cancer Res., 71, 19, 10.1158/0008-5472.CAN-10-2602
Djonov, 2001, Vascular remodelling during the normal and malignant life cycle of the mammary gland, Microsc. Res. Tech., 52, 182, 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.0.CO;2-M
Djonov, 2002, Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism, Dev. Dyn., 224, 391, 10.1002/dvdy.10119
Duarte, 2004, Dosage-sensitive requirement for mouse Dll4 in artery development, Genes Dev., 18, 2474, 10.1101/gad.1239004
Duda, 2010, Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer, Oncologist, 15, 577, 10.1634/theoncologist.2010-0029
Dudley, 2010, Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors, Blood, 116, 3367, 10.1182/blood-2010-02-271122
Dufraine, 2008, Notch signaling regulates tumor angiogenesis by diverse mechanisms, Oncogene, 27, 5132, 10.1038/onc.2008.227
Ebos, 2007, Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy, Proc. Natl. Acad. Sci. USA, 104, 17069, 10.1073/pnas.0708148104
Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021
Escudier, 2010, Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival, J. Clin. Oncol., 28, 2144, 10.1200/JCO.2009.26.7849
Fan, 2011, Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration, Br. J. Cancer, 10.1038/bjc.2011.81
Fang, 2011, Stem cells in tumor angiogenesis, J. Mol. Cell. Cardiol., 50, 290, 10.1016/j.yjmcc.2010.10.024
Ferrara, 1996, Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene, Nature, 380, 439, 10.1038/380439a0
Ferrari, 2003, Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors, Gene Ther., 10, 647, 10.1038/sj.gt.3301883
Fischer, 2008, FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nature reviews, Cancer, 8, 942
Fong, 1995, Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium, Nature, 376, 66, 10.1038/376066a0
Fraisl, 2009, Regulation of angiogenesis by oxygen and metabolism, Dev. Cell, 16, 167, 10.1016/j.devcel.2009.01.003
Friedl, 2009, Collective cell migration in morphogenesis, regeneration and cancer, Nat. Rev. Mol. Cell Biol., 10, 445, 10.1038/nrm2720
Fukumura, 2007, Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization, Microvasc. Res., 74, 72, 10.1016/j.mvr.2007.05.003
Gale, 2001, Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells, Dev. Biol., 230, 151, 10.1006/dbio.2000.0112
Gale, 2004, Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development, Proc. Natl. Acad. Sci. USA, 101, 15949, 10.1073/pnas.0407290101
Gao, 2008, Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis, Science, 319, 195, 10.1126/science.1150224
Garcia-Barros, 2003, Tumor response to radiotherapy regulated by endothelial cell apoptosis, Science, 300, 1155, 10.1126/science.1082504
Gerety, 1999, Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development, Mol. Cell, 4, 403, 10.1016/S1097-2765(00)80342-1
Gerhardt, 2003, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J. Cell Biol., 161, 1163, 10.1083/jcb.200302047
Goodison, 2003, Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 9, 3808
Gothert, 2004, Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium, Blood, 104, 1769, 10.1182/blood-2003-11-3952
Grothey, 2008, Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107, J. Clin. Oncol., 26, 183, 10.1200/JCO.2007.13.8099
Grothey, 2008, Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE), J. Clin. Oncol., 26, 5326, 10.1200/JCO.2008.16.3212
Grunewald, 2006, VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells, Cell, 124, 175, 10.1016/j.cell.2005.10.036
Hagberg, 2010, Vascular endothelial growth factor B controls endothelial fatty acid uptake, Nature, 464, 917, 10.1038/nature08945
Hagedorn, 2004, VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis, Dev. Dyn., 230, 23, 10.1002/dvdy.20020
Hamzah, 2008, Vascular normalization in Rgs5-deficient tumours promotes immune destruction, Nature, 453, 410, 10.1038/nature06868
Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7
Hassan, 2010, CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model, Int. J. Cancer
Hellstrom, 1999, Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse, Development, 126, 3047, 10.1242/dev.126.14.3047
Hendrix, 2001, Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry, Proc. Natl. Acad. Sci. USA, 98, 8018, 10.1073/pnas.131209798
Hendrix, 2003, Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma, Nat. Rev. Cancer, 3, 411, 10.1038/nrc1092
Hess, 2001, Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2), Cancer Res., 61, 3250
Hess, 2006, VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry, Cancer Biol. Ther., 5, 228, 10.4161/cbt.5.2.2510
Hiratsuka, 2006, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat. Cell Biol., 8, 1369, 10.1038/ncb1507
Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994
Holmgren, 1995, Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression, Nat. Med., 1, 149, 10.1038/nm0295-149
Hurwitz, 2004, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer, N. Engl. J. Med., 350, 2335, 10.1056/NEJMoa032691
Hurwitz, 2010, Analysis of early hypertension (HTN) and clinical outcome with bevacizumab (BV), ASCO Meeting Abstracts, 28, 3039
Igreja, 2007, Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients, Haematologica, 92, 469, 10.3324/haematol.10723
Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819
Jin, 2006, Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes, Nat. Med., 12, 557, 10.1038/nm1400
Jubb, 2010, Biomarkers to predict the clinical efficacy of bevacizumab in cancer, Lancet Oncol., 11, 1172, 10.1016/S1470-2045(10)70232-1
Kamihata, 2001, Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines, Circulation, 104, 1046, 10.1161/hc3501.093817
Kamoun, 2009, Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice, J. Clin. Oncol., 27, 2542, 10.1200/JCO.2008.19.9356
Kaplan, 2005, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, 438, 820, 10.1038/nature04186
Karkkainen, 2004, Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins, Nat. Immunol., 5, 74, 10.1038/ni1013
Kawasaki, 1999, A requirement for neuropilin-1 in embryonic vessel formation, Development, 126, 4895, 10.1242/dev.126.21.4895
Kearney, 2002, Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division, Blood, 99, 2397, 10.1182/blood.V99.7.2397
Kilarski, 2009, Biomechanical regulation of blood vessel growth during tissue vascularization, Nat. Med., 15, 657, 10.1038/nm.1985
Kobayashi, 2002, Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256), Cancer Res., 62, 860
Koch, 2009, VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis, J. Pathol., 219, 356, 10.1002/path.2605
Koh, 2010, Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage, Cancer Cell, 18, 171, 10.1016/j.ccr.2010.07.001
Krebs, 2004, Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants, Genes Dev., 18, 2469, 10.1101/gad.1239204
Kunkel, 2001, Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2, Cancer Res., 61, 6624
Lawson, 2001, Notch signaling is required for arterial-venous differentiation during embryonic vascular development, Development, 128, 3675, 10.1242/dev.128.19.3675
Leveen, 1994, Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities, Genes Dev., 8, 1875, 10.1101/gad.8.16.1875
Li, 2007, Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo, Cancer Res., 67, 11244, 10.1158/0008-5472.CAN-07-0969
Lissitzky, 2009, Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro, Cancer Res., 69, 802, 10.1158/0008-5472.CAN-08-2391
Lohela, 2009, VEGFs and receptors involved in angiogenesis versus lymphangiogenesis, Curr. Opin. Cell Biol., 21, 154, 10.1016/j.ceb.2008.12.012
Luzzi, 1998, Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases, Am. J. Pathol., 153, 865, 10.1016/S0002-9440(10)65628-3
Lyden, 2001, Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat. Med., 7, 1194, 10.1038/nm1101-1194
Ma, 2010, Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model, Nat. Biotechnol., 28, 341, 10.1038/nbt.1618
Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55
Mancuso, 2006, Rapid vascular regrowth in tumors after reversal of VEGF inhibition, J. Clin. Invest., 116, 2610, 10.1172/JCI24612
Maniotis, 1999, Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry, Am. J. Pathol., 155, 739, 10.1016/S0002-9440(10)65173-5
Maniotis, 2002, Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix, Lab. Invest.; J. Tech. Methods Pathol., 82, 1031, 10.1097/01.LAB.0000024362.12721.67
Mazzone, 2009, Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization, Cell, 136, 839, 10.1016/j.cell.2009.01.020
McAllister, 2010, The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts, J. Cutan. Pathol., 37, 19, 10.1111/j.1600-0560.2010.01503.x
Miles, 2011, Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials, J. Clin. Oncol., 29, 83, 10.1200/JCO.2010.30.2794
Mizobe, 2008, Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma, Oncol. Rep., 20, 517
Mourad-Zeidan, 2008, Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry, Am. J. Pathol., 173, 1839, 10.2353/ajpath.2008.080380
Naik, 2008, Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer, Breast Cancer Res. Treat., 107, 133, 10.1007/s10549-007-9519-6
Naumov, 2002, Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy, Cancer Res., 62, 2162
Nguyen, 2009, Metastasis: from dissemination to organ-specific colonization, Nat. Rev. Cancer, 9, 274, 10.1038/nrc2622
Nico, 2010, Intussusceptive microvascular growth in human glioma, Clin. Exp. Med., 10, 93, 10.1007/s10238-009-0076-7
Noguera-Troise, 2006, Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis, Nature, 444, 1032, 10.1038/nature05355
Nolan, 2007, Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization, Genes Dev., 21, 1546, 10.1101/gad.436307
Norden, 2009, Antiangiogenic therapies for high-grade glioma, Nat. Rev. Neurol., 5, 610, 10.1038/nrneurol.2009.159
Olsson, 2006, VEGF receptor signalling - in control of vascular function, Nat. Rev. Mol. Cell Biol., 7, 359, 10.1038/nrm1911
Paez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027
Pan, 2007, Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth, Cancer Cell, 11, 53, 10.1016/j.ccr.2006.10.018
Parati, 2002, Human neural stem cells express extra-neural markers, Brain Res., 925, 213, 10.1016/S0006-8993(01)03291-7
Pasquier, 2010, Metronomic chemotherapy: new rationale for new directions, Nat. Rev. Clin. Oncol., 7, 455, 10.1038/nrclinonc.2010.82
Passalidou, 2002, Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas, Br. J. Cancer, 86, 244, 10.1038/sj.bjc.6600015
Patan, 2001, Vascular morphogenesis and remodeling in a human tumor xenograft: blood vessel formation and growth after ovariectomy and tumor implantation, Circ. Res., 89, 732, 10.1161/hh2001.097872
Peters, 2005, Contribution of bone marrow-derived endothelial cells to human tumor vasculature, Nat. Med., 11, 261, 10.1038/nm1200
Poesen, 2008, Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration, J. Neurosci., 28, 10451, 10.1523/JNEUROSCI.1092-08.2008
Purhonen, 2008, Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth, Proc. Natl. Acad. Sci. USA, 105, 6620, 10.1073/pnas.0710516105
Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014
Ratner, 2011, Fearful of Avastin’s fate, Genentech asks for unusual hearing, Nat. Med., 17, 233, 10.1038/nm0311-233
Reck, 2010, Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL), Ann. Oncol., 21, 1804, 10.1093/annonc/mdq020
Red-Horse, 2010, Coronary arteries form by developmental reprogramming of venous cells, Nature, 464, 549, 10.1038/nature08873
Rehman, 2003, Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors, Circulation, 107, 1164, 10.1161/01.CIR.0000058702.69484.A0
Ribatti, 2005, Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma, Oncol. Rep., 14, 81
Ricci-Vitiani, 2010, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, Nature, 468, 824, 10.1038/nature09557
Ridgway, 2006, Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis, Nature, 444, 1083, 10.1038/nature05313
Rolny, 2011, HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF, Cancer Cell, 19, 31, 10.1016/j.ccr.2010.11.009
Ronzoni, 2010, Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients, Ann. Oncol., 21, 2382, 10.1093/annonc/mdq261
Rubenstein, 2000, Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption, Neoplasia, 2, 306, 10.1038/sj.neo.7900102
Rubin, 2003, A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors, Proc. Natl. Acad. Sci. USA, 100, 13513, 10.1073/pnas.2235846100
Ruf, 2003, Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry, Cancer Res., 63, 5381
Ruiz de Almodovar, 2009, Role and therapeutic potential of VEGF in the nervous system, Physiol. Rev., 89, 607, 10.1152/physrev.00031.2008
Sato, 1995, Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation, Nature, 376, 70, 10.1038/376070a0
Schneider, 2008, Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100, J. Clin. Oncol., 26, 4672, 10.1200/JCO.2008.16.1612
Seftor, 2002, Molecular determinants of human uveal melanoma invasion and metastasis, Clin. Exp. Metastasis, 19, 233, 10.1023/A:1015591624171
Segarra, 2008, Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth, Blood, 112, 1904, 10.1182/blood-2007-11-126045
Seruga, 2008, Intermittent androgen blockade should be regarded as standard therapy in prostate cancer, Nat. Clin. Pract. Oncol., 5, 574, 10.1038/ncponc1180
Shaked, 2006, Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors, Science, 313, 1785, 10.1126/science.1127592
Shaked, 2008, Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents, Cancer Cell, 14, 263, 10.1016/j.ccr.2008.08.001
Shalaby, 1995, Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice, Nature, 376, 62, 10.1038/376062a0
Sharma, 2002, Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry, Prostate, 50, 189, 10.1002/pros.10048
Shin, 2001, Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization, Dev. Biol., 230, 139, 10.1006/dbio.2000.9957
Shirakawa, 2002, Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft, Cancer Res., 62, 560
Shyy, 1994, Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium, Proc. Natl. Acad. Sci. USA, 91, 4678, 10.1073/pnas.91.11.4678
Sini, 2008, Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics, Cancer Res., 68, 1581, 10.1158/0008-5472.CAN-06-4685
Soda, 2011, Feature Article: Transdifferentiation of glioblastoma cells into vascular endothelial cells, Proc. Natl Acad. Sci. USA, 10.1073/pnas.1016030108
Sood, 2002, The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy, Cancer Biol. Ther., 1, 661, 10.4161/cbt.316
Sorensen, 2009, A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients, Cancer Res., 69, 5296, 10.1158/0008-5472.CAN-09-0814
Spring, 2005, Chemokines direct endothelial progenitors into tumor neovessels, Proc. Natl. Acad. Sci. USA, 102, 18111, 10.1073/pnas.0507158102
Stockmann, 2008, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis, Nature, 456, 814, 10.1038/nature07445
Stommel, 2007, Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies, Science, 318, 287, 10.1126/science.1142946
Sullivan, 2007, Hypoxia-driven selection of the metastatic phenotype, Cancer Metastasis Rev., 26, 319, 10.1007/s10555-007-9062-2
Suri, 1996, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis, Cell, 87, 1171, 10.1016/S0092-8674(00)81813-9
Tammela, 2010, Lymphangiogenesis: Molecular mechanisms and future promise, Cell, 140, 460, 10.1016/j.cell.2010.01.045
Teicher, 2011, Antiangiogenic agents and targets: A perspective, Biochem. Pharmacol., 81, 6, 10.1016/j.bcp.2010.09.023
Thies, 2001, PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma, J. Pathol., 195, 537, 10.1002/path.988
Thurston, 1999, Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1, Science, 286, 2511, 10.1126/science.286.5449.2511
Tol, 2009, Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer, N. Engl. J. Med., 360, 563, 10.1056/NEJMoa0808268
Valachis, 2010, Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials, Breast Cancer Res. Treat., 122, 1, 10.1007/s10549-009-0727-0
Van Cutsem, 2009, Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer, N. Engl. J. Med., 360, 1408, 10.1056/NEJMoa0805019
Van Cutsem, 2009, Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3, J. Clin. Oncol., 27, 3117, 10.1200/JCO.2008.21.6663
Van Cutsem, 2009, Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study, Ann. Oncol., 20, 1842, 10.1093/annonc/mdp233
van der Schaft, 2005, Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia, Cancer Res., 65, 11520, 10.1158/0008-5472.CAN-05-2468
Verheul, 2007, Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model, Clin. Cancer Res., 13, 4201, 10.1158/1078-0432.CCR-06-2553
Wang, 1998, Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4, Cell, 93, 741, 10.1016/S0092-8674(00)81436-1
Wang, 2010, Glioblastoma stem-like cells give rise to tumour endothelium, Nature, 468, 829, 10.1038/nature09624
Warso, 2001, Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 7, 473
Welch, 2010, Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review, Ann. Oncol., 21, 1152, 10.1093/annonc/mdp533
Wickersheim, 2009, Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors, Int. J. Cancer, 125, 1771, 10.1002/ijc.24605
Williams, 2006, Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function, Blood, 107, 931, 10.1182/blood-2005-03-1000
Wilson, 2006, Bone-marrow haematopoietic-stem-cell niches, Nat. Rev. Immunol., 6, 93, 10.1038/nri1779
Wilting, 1996, VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane, Dev. Biol., 176, 76, 10.1006/dbio.1996.9993
Winkler, 2004, Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases, Cancer Cell, 6, 553
Winnik, 2009, HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2, Cardiovasc. Res., 83, 558, 10.1093/cvr/cvp133
Wurmser, 2004, Cell fusion-independent differentiation of neural stem cells to the endothelial lineage, Nature, 430, 350, 10.1038/nature02604
Yachida, 2010, Distant metastasis occurs late during the genetic evolution of pancreatic cancer, Nature, 467, 1114, 10.1038/nature09515
Zagzag, 2000, Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis, Lab. Invest.; J. Tech. Methods Pathol., 80, 837, 10.1038/labinvest.3780088
Zagzag, 2006, Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion, Lab. Invest., 86, 1221, 10.1038/labinvest.3700482
Zhang, 2010, Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects, Clin. Cancer Res., 16, 3420, 10.1158/1078-0432.CCR-09-2904
Zhu, 2010, Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study, Lancet Oncol., 11, 48, 10.1016/S1470-2045(09)70333-X